Timir Paul, MD, PhD, FSCAI; Hady Lichaa, MD, FSCAI; Konstantinos Dean Boudoulas, MD, FSCAI Approximately 6.8% of healthy adults aged > 65 years have renal artery stenosis (RAS) with a higher prevalence among those with cardiovascular (CV) risk factors, which is a marker of poorer prognosis. 1 It is estimated that ~10% of hypertensive patients in the US have resistant hypertension, and RAS is a common secondary cause (5%-34%). 2 The CORAL trial demonstrated that renal artery stenting is not associated